General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsOklahoma stuck with over a million hydroxychloroquine doses
Idiots who listen to the former guy are paying the price for their stupidity
Link to tweet
The 1.2 million doses of the drug normally used to treat lupus, rheumatoid arthritis and prevent malaria were shipped from a California distributor to a small pharmacy in Pryor, with the state paying for the hydroxychloroquine from money borrowed from fees generated by medical marijuana licenses.
The hydroxychloroquine now sits in a warehouse at an undisclosed location, with the Oklahoma State Department of Health reluctant to answer questions about what it will do with the drug or why it went to Pryor. Records obtained by Oklahoma Watch show the drug has an expiration date in December. Meanwhile, lupus and rheumatoid arthritis patients had to navigate a temporary shortage related to a spike in demand related to the drugs supposed COVID-19 usage.
In the early weeks of the pandemic, former Secretary of Health Jerome Loughridge authorized the purchase of up to $3 million of hydroxychloroquine from California-based FFF Enterprises Inc., according to an April 3, 2020 memo.
4Q2u2
(1,406 posts)To Brazil. Trumpolino will buy them.
Paladin
(28,254 posts)Retain a few thousand doses, to be shoved up trump's ass.
DURHAM D
(32,609 posts)It was never that. It was always quackary. Pretty sure the Governor received a bribe to spend tax dollars on something that stupid.
Aristus
(66,328 posts)Show 'em how it's done!
belpejic
(720 posts)Oklahoman GQPers?
Seriously, donate the hydroxys to people who actually need them for their intended uses, since it has been overwhelmingly determined that this medicine does nothing for COVID-19.
NightWatcher
(39,343 posts)I couldn't get my stuff for a month last year because of the orange anus, so now send your meds to me. I'll send them to my fellow lupis
WarGamer
(12,440 posts)This is the NIH summary of the HCQ study:
https://www.nih.gov/news-events/news-releases/hydroxychloroquine-does-not-benefit-adults-hospitalized-covid-19